77,182 XNAS Volume
XNAS 28 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Fred Aslan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 200,000 | 416,665 | - | 0 | Common Stock | |
| Heather Raymon | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 33,350 | 43,350 | - | 0 | Common Stock | |
| Neha Krishnamohan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 60,000 | 110,000 | - | 0 | Common Stock | |
| Christopher Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 60,000 | 85,000 | - | 0 | Common Stock | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 86,650 | 159,449 | - | 0 | Common Stock | |
| Thorsten Graef | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 60,000 | 80,000 | - | 0 | Common Stock | |
| Daniel G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 27,500 | 27,500 | - | - | Director Stock Option (Right to Buy) | |
| Heather Raymon | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 10,000 | 10,000 | - | 0 | Common Stock | |
| Neha Krishnamohan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 50,000 | 50,000 | - | 0 | Common Stock | |
| Christopher Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 25,000 | 25,000 | - | 0 | Common Stock | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 50,000 | 72,799 | - | 0 | Common Stock | |
| Thorsten Graef | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 20,000 | 20,000 | - | 0 | Common Stock | |
| Yong-Jun Huh | Director | 22 Jul 2024 | 62,181 | 0 | - | - | Series B Preferred Stock | ||
| Yong-Jun Huh | Director | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 22 Jul 2024 | 1,666,666 | 3,306,900 | - | 12 | 19,999,992 | Common Stock |
| Yong-Jun Huh | Director | 22 Jul 2024 | 292,791 | 525,349 | - | - | Common Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 62,181 | 587,530 | - | - | Common Stock | ||
| Yong-Jun Huh | Director | Other type of transaction at price $ 10.20 per share. | 22 Jul 2024 | 256,316 | 843,846 | - | 10.2 | 2,614,423 | Common Stock |
| Yong-Jun Huh | Director | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 22 Jul 2024 | 416,666 | 1,260,512 | - | 12 | 4,999,992 | Common Stock |
| Yong-Jun Huh | Director | 22 Jul 2024 | 330,095 | 1,346,117 | - | - | Common Stock | ||
| Yong-Jun Huh | Director | Other type of transaction at price $ 10.20 per share. | 22 Jul 2024 | 294,117 | 1,640,234 | - | 10.2 | 2,999,993 | Common Stock |
| Yong-Jun Huh | Director | 22 Jul 2024 | 667,185 | 0 | - | - | Series A Preferred Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 330,095 | 0 | - | - | Series B Preferred Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 292,791 | 0 | - | - | Series A Preferred Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 667,185 | 1,016,022 | - | - | Common Stock | ||
| Fred Aslan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 228,905 | 228,905 | - | 0 | Common Stock | |
| Fred Aslan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 343,811 | 343,811 | - | - | Employee Stock Option (Right to Buy) |